W hen president-elect Donald Trump announced that he would nominate Robert F Kennedy Jr to be his secretary of Health and Human Services, the move shocked many. Kennedy, the son of the late senator ...
In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
IQVIA reported annual sales for the twelve months ending September 2024 of $4.3 billion for the brand and generic market for this product. About Elite Pharmaceuticals, Inc.
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
WASHINGTON (AP) — Robert F. Kennedy Jr., an anti-vaccine activist and environmentalist, for years gained a loyal and fierce ...
Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Federal health scientists brace for RFK Jr.'s potential takeover, with some readying résumés or retirement plans.
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...
This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback